[{"id":"e307aa65-970c-414e-b936-4d62cf1a11e3","acronym":"TARGLIO","url":"https://clinicaltrials.gov/study/NCT04967690","created_at":"2021-07-19T14:52:42.852Z","updated_at":"2024-07-02T16:35:43.752Z","phase":"Phase 1","brief_title":"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM","source_id_and_acronym":"NCT04967690 - TARGLIO","lead_sponsor":"Double Bond Pharmaceutical AB","biomarkers":" MGMT","pipe":"","alterations":" ","tags":["MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Temodex (temozolomide gel)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 27","initiation":"Initiation: 01/01/2024","start_date":" 01/01/2024","primary_txt":" Primary completion: 07/01/2025","primary_completion_date":" 07/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-07-06"}]